Radioactive iodine (I-131) is the gold standard treatment for feline hyperthyroidism, offering a permanent cure with minimal welfare impact compared to lifelong medication management.
I-131 treatment represents a particularly elegant welfare solution: a single, non-invasive treatment that permanently resolves a condition that would otherwise require twice-daily medication for the rest of the cat's life. The temporary isolation period is a welfare cost, but for most cats this is significantly preferable to the long-term burden of daily handling for medication and the potential side effects of chronic medication use. The primary welfare challenge is the kidney disease unmasking effect — thyroid hormone maintains kidney perfusion, and normalizing thyroid function can reveal underlying CKD. This requires careful monitoring in older cats to ensure the cure does not create a new welfare problem.